Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Alzheimer's Disease

Free Subscription 26.04.2021 1 Acta Neuropathol 3 Alzheimers Dement 4 Biol Psychiatry 1 BMC Geriatr 1 BMC Neurol 6 Brain 2 Curr Alzheimer Res 1 Exp Neurol 13 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Neurosci 1 MMWR Morb Mortal Wkly Rep 2 Neurochem Res 1 Neurology 1 Neurosci Lett 1 Neuroscience 2 PLoS Genet 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. VALVERDE A, Dunys J, Lorivel T, Debayle D, et al
   Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain.
   Acta Neuropathol. 2021 Apr 21. pii: 10.1007/s00401-021-02308.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. RANASINGHE KG, Petersen C, Kudo K, Mizuiri D, et al
   Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.
   Alzheimers Dement. 2021 Apr 21. doi: 10.1002/alz.12349.
   PubMed         Abstract available
   
   
3. LI X, Tsolis KC, Koper MJ, Ronisz A, et al
   Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease.
   Alzheimers Dement. 2021 Apr 19. doi: 10.1002/alz.12345.
   PubMed         Abstract available
   
   
4. SABBAGH MN, Cummings J
   Open Peer Commentary to "Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019".
   Alzheimers Dement. 2021;17:702-703.
   PubMed        
   
   

   
   Biol Psychiatry

5. XU W, Feng W, Shen XN, Bi YL, et al
   Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia.
   Biol Psychiatry. 2021;89:766-775.
   PubMed         Abstract available
   
   
6. MACKIN RS, Insel PS
   Reply to: Brain Amyloid Deposition in Late-Life Depression.
   Biol Psychiatry. 2020 Nov 11. pii: S0006-3223(20)31949.
   PubMed        
   
   
7. POMARA N, Imbimbo BP
   Brain Amyloid Deposition in Late-Life Depression.
   Biol Psychiatry. 2020 Nov 11. pii: S0006-3223(20)31948.
   PubMed        
   
   
8. VAN DYCK CH, O'Dell RS, Mecca AP
   Amyloid-Associated Depression-or Not?
   Biol Psychiatry. 2021;89:737-738.
   PubMed        
   
   

   
   BMC Geriatr

9. LU Y, Liu C, Yu D, Fawkes S, et al
   Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review.
   BMC Geriatr. 2021;21:10.
   PubMed         Abstract available
   
   

   
   BMC Neurol

10. QIAN S, Chen K, Guan Q, Guo Q, et al
    Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2021;21:172.
    PubMed         Abstract available
    
    

    
    Brain

11. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    PubMed         Abstract available
    
    
12. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    PubMed         Abstract available
    
    
13. 
    Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    PubMed        
    
    
14. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    PubMed         Abstract available
    
    
15. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    PubMed         Abstract available
    
    
16. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

17. GALLINI A, Jegou D, Lapeyre-Mestre M, Couret A, et al
    Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data.
    Curr Alzheimer Res. 2021 Apr 15. pii: CAR-EPUB-115358.
    PubMed         Abstract available
    
    
18. PATHAK GA, Barbe RC, Phillips NR
    Multiomics Investigation of Hypertension and White Matter Hyperintensity as a Source of Vascular Dementia or a Comorbidity to Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Apr 22. pii: CAR-EPUB-115443.
    PubMed         Abstract available
    
    

    
    Exp Neurol

19. MCKNIGHT I, Hart C, Park IH, Shim JW, et al
    Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
    Exp Neurol. 2021;335:113523.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

20. DAVIDOWITZ EJ, Krishnamurthy PK, Lopez P, Jimenez H, et al
    In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    J Alzheimers Dis. 2020;73:147-161.
    PubMed         Abstract available
    
    
21. PARVAND M, Rankin CH
    Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
    J Alzheimers Dis. 2020;73:1-21.
    PubMed         Abstract available
    
    
22. VERGOUW LJM, Bosman B, van de Beek M, Salome M, et al
    Family History is Associated with Phenotype in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2020;73:269-275.
    PubMed         Abstract available
    
    
23. TSUNODA K, Yamashita T, Osakada Y, Sasaki R, et al
    Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020;73:209-215.
    PubMed         Abstract available
    
    
24. BREWER GJ, Herrera RA, Philipp S, Sosna J, et al
    Age-Related Intraneuronal Aggregation of Amyloid-beta in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    J Alzheimers Dis. 2020;73:229-246.
    PubMed         Abstract available
    
    
25. SUNDSTROM A, Sorman DE, Hansson P, Ljungberg JK, et al
    Mental Demands at Work and Risk of Dementia.
    J Alzheimers Dis. 2020;74:735-740.
    PubMed         Abstract available
    
    
26. ZHANG J, Hua XF, Gu J, Chen F, et al
    High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2020;74:851-864.
    PubMed         Abstract available
    
    
27. RICHARDSON K, Wharton SB, Grossi CM, Matthews FE, et al
    Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
    J Alzheimers Dis. 2020;74:999-1009.
    PubMed         Abstract available
    
    
28. GRONTVEDT GR, Lauridsen C, Berge G, White LR, et al
    The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.
    J Alzheimers Dis. 2020;74:829-837.
    PubMed         Abstract available
    
    
29. WATT G, Shang K, Zieba J, Olaya J, et al
    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Abeta40 Levels in 12-Month-Old Male AbetaPPswe/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2020;74:937-950.
    PubMed         Abstract available
    
    
30. ARNALDI D, Donniaquio A, Mattioli P, Massa F, et al
    Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191315. doi: 10.3233/JAD-191315.
    PubMed         Abstract available
    
    
31. KRESGE HA, Liu D, Gupta DK, Moore EE, et al
    Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    J Alzheimers Dis. 2020;74:965-974.
    PubMed         Abstract available
    
    
32. ARFANAKIS K, Evia AM, Leurgans SE, Cardoso LFC, et al
    Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    J Alzheimers Dis. 2020;73:333-345.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

33. LAM S, Lipton RB, Harvey DJ, Zammit AR, et al
    White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    J Am Geriatr Soc. 2021 Apr 23. doi: 10.1111/jgs.17173.
    PubMed         Abstract available
    
    

    
    J Neurosci

34. VAN SKIKE CE, Hussong SA, Hernandez SF, Banh AQ, et al
    mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease.
    J Neurosci. 2021 Apr 20. pii: JNEUROSCI.2144-20.2021.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

35. 
    QuickStats: Age-Adjusted Death Rates* for Alzheimer Disease(dagger) Among Adults Aged >/=65 Years, by Sex - National Vital Statistics System, United States, 1999-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:602.
    PubMed        
    
    

    
    Neurochem Res

36. NAZIR S, Anwar F, Saleem U, Ahmad B, et al
    Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.
    Neurochem Res. 2021 Apr 20. pii: 10.1007/s11064-021-03327.
    PubMed         Abstract available
    
    
37. UDDIN MS, Sumsuzzman DM, Jeandet P, Behl T, et al
    Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.
    Neurochem Res. 2021 Apr 19. pii: 10.1007/s11064-021-03325.
    PubMed         Abstract available
    
    

    
    Neurology

38. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease.
    Neurology. 2021 Apr 19. pii: WNL.0000000000012024.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

39. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    PubMed         Abstract available
    
    

    
    Neuroscience

40. JUNG H, Yi D, Soo Byun M, Ho Lee J, et al
    Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease.
    Neuroscience. 2021 Apr 15. pii: S0306-4522(21)00179.
    PubMed         Abstract available
    
    

    
    PLoS Genet

41. MARQUILLY C, Busto GU, Leger BS, Boulanger A, et al
    Htt is a repressor of Abl activity required for APP-induced axonal growth.
    PLoS Genet. 2021;17:e1009287.
    PubMed         Abstract available
    
    
42. BAIRD DA, Liu JZ, Zheng J, Sieberts SK, et al
    Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    PLoS Genet. 2021;17:e1009224.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

43. LORD J, Jermy B, Green R, Wong A, et al
    Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: